Silo Pharma (SILO) Assets (2010 - 2026)
Silo Pharma (SILO) posted Assets of $7.0 million for Q1 2026, down 7.72% sequentially from $7.6 million in Q4 2025, and up 18.95% YoY from $5.9 million in Q1 2025.
Silo Pharma (SILO) Assets (2010 - 2026) Analysis & Trends
Silo Pharma has reported Assets for 14 years, with the latest figure at $7.0 million in Q1 2026.
- Quarterly Assets rose 18.95% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 18.95% YoY) and the FY2025 annual result came in at $7.6 million, up 2.61% from the prior year.
- Assets declined to $7.0 million in Q1 2026 per SILO's latest filing, from $7.6 million in the prior quarter.
- Over five years, Assets peaked at $13.0 million in Q3 2022 and troughed at $5.9 million in Q1 2025.
- A 5-year average of $8.6 million and a median of $8.0 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets jumped 80.75% in 2022, then slumped 37.03% in 2024.
- Over 5 years, Assets stood at $11.6 million in 2022, then slumped by 33.47% to $7.7 million in 2023, then declined by 4.32% to $7.4 million in 2024, then increased by 2.61% to $7.6 million in 2025, then retreated by 7.72% to $7.0 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $7.0 million, $7.6 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 19.82 Bn |
| 10 | Silo Pharma | 3.03 Mn | 3.03 Mn | - | 5.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.95 Mn |
| Mar 31, 2026 | 7.02 Mn |
| Dec 31, 2025 | 7.61 Mn |
| Sep 30, 2025 | 6.38 Mn |
| Jun 30, 2025 | 6.65 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 7.41 Mn |
| Sep 30, 2024 | 8.57 Mn |
| Jun 30, 2024 | 8.04 Mn |
| Mar 31, 2024 | 6.94 Mn |
| Dec 31, 2023 | 7.75 Mn |
| Sep 30, 2023 | 8.99 Mn |
| Jun 30, 2023 | 10.25 Mn |
| Mar 31, 2023 | 11.02 Mn |
| Dec 31, 2022 | 11.64 Mn |
| Sep 30, 2022 | 13.05 Mn |
| Jun 30, 2022 | 9.04 Mn |
| Mar 31, 2022 | 9.72 Mn |
| Dec 31, 2021 | 10.49 Mn |
| Sep 30, 2021 | 11.39 Mn |